Susan Lemons Consulting, LLC

11/08/2022

06/23/2020

Let's pray this works.

Johnson & Johnson has accelerated the initiation of the Phase 1/2a first-in-human clinical trial of its investigational SARS-CoV-2 vaccine.

05/06/2020

Getting ready

Catalent’s Biologics business unit will accelerate availability of manufacturing capacity and prepare for large-scale commercial manufacturing of Johnson & Johnson’s lead vaccine candidate for COVID-19.

03/24/2020

More help.

Novartis announced its commitment to donate up to 130 million doses of generic hydroxychloroquine to support the global COVID-19 pandemic response.

03/17/2020

More positive news

Thermo Fisher Scientific announced the FDA issued an EUA for its diagnostic test that can be used immediately to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19.

03/17/2020

Some positive news.

Pfizer and BioNTech announced the companies have agreed to a letter of intent regarding the co-development and distribution of a potential mRNA-based coronavirus vaccine aimed at preventing COVID-19 infection.